Publicacións (22) Publicacións de Andrés López Muñiz

2024

  1. Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice

    Clinical Kidney Journal, Vol. 17, Núm. 4

2023

  1. Postoperative Events in Incompatible Living Donor Kidney Transplant Recipients Undergoing Prior Desensitization

    Transplantation Proceedings, Vol. 55, Núm. 7, pp. 1575-1580

2022

  1. Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients

    Life, Vol. 12, Núm. 12

2021

  1. Edema Associated With Everolimus de Novo

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2681-2684

  2. Isoagglutinin Titers in ABO-Incompatible Kidney Transplant

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2675-2677

2019

  1. ABO incompatible live donor renal transplant. Study of 48 patients after desensitization

    Nefrologia, Vol. 39, Núm. 6, pp. 612-622

  2. Trasplante renal de donante vivo ABO incompatible. Estudio de 48 pacientes tras desensibilización

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 39, Núm. 6, pp. 612-622

2016

  1. Identification of targets for prevention of peritoneal catheter tunnel and exit-site infections in low incidence settings

    Peritoneal Dialysis International, Vol. 36, Núm. 1, pp. 43-51

  2. Inhibition of gastric acid secretion by H2 receptor antagonists associates a definite risk of enteric peritonitis and infectious mortality in patients treated with peritoneal dialysis

    PLoS ONE, Vol. 11, Núm. 2

  3. Serum levels of the adipomyokine irisin in patients with chronic kidney disease

    Nefrologia, Vol. 36, Núm. 5, pp. 496-502

2014

  1. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis

    Peritoneal Dialysis International, Vol. 34, Núm. 6, pp. 618-626

2012

  1. Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis

    Nefrologia, Vol. 32, Núm. 6, pp. 782-789

  2. Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 1, pp. 369-374

  3. Getting the right patient on the right renal replacement therapy

    Contributions to Nephrology, Vol. 178, pp. 40-46

  4. Hipertrofia ventricular izquierda severa e insuficiencia renal terminal de etiología incierta: ¿Enfermedad de Fabry?

    Revista Clinica Espanola

2011

  1. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: Study protocol

    BMC Cardiovascular Disorders, Vol. 11

  2. Treatment of transplant renal artery stenosis by percutaneous transluminal angioplasty and/or stenting: Study in 63 patients in a single institution

    Transplantation Proceedings, Vol. 43, Núm. 6, pp. 2205-2207

2010

  1. Análisis del transporte peritoneal de potasio mediante pruebas de equilibrio peritoneal con diferentes concentraciones de glucosa

    Nefrologia, Vol. 30, Núm. 1, pp. 95-102

  2. Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients

    Nephron - Clinical Practice, Vol. 116, Núm. 2

  3. Peritoneal total protein transport assessed from peritoneal equilibration tests using different dialysate glucose concentrations

    Peritoneal Dialysis International, Vol. 30, Núm. 5, pp. 549-557